Patent ID: 8008012
Filing Date: 2011-08-30
Classification: C12Q,G01N,G06K

Abstract:
1. A method for screening for the presence of prostate cancer in a patient comprising: detecting within a patient sample comprising prostate cells each polynucleotide of a combination of polynucleotides consisting of SLC14A1 (SEQ ID NO. 1), FER1L3 (SEQ ID NO. 2) and ANXA6 (SEQ ID NO. 3); comparing levels of the polynucleotides to a control sample comprising prostate cells taken from a control subject not having prostate cancer, wherein the patient sample and the control sample are of a same sample type; wherein decreased levels of each of the polynucleotides in the combination in the patient sample relative to the control sample are indicative of prostate cancer.